Clinical trial
A Open Multi-center Clinical Study on Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
NCT01897831 is registered in ClinicalTrials.gov with Xiangbei Welman Pharmaceutical Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Open Multi-center Clinical Study on Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
- Lead sponsor
- Xiangbei Welman Pharmaceutical Co., Ltd
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 31, 2011
- Completion date
- November 30, 2015
- Enrollment
- 2,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.